Alecia Barry

Alecia Barry, PhD, joined Gilead in 2022 as Clinical Operations Franchise Head for Breast, Gynaecological and Genito-urinary Cancers.   In her current role, Alecia oversees and leads a large group of oncology Clinical Operations professionals with global scope and accountability for operational strategy definition and trial execution to meet cost, speed and quality standards.  Alecia serves a thought partner to the Oncology Clinical Development Franchise Heads providing strategic operational leadership and expertise. She is a member of the Clinical Operations Oncology Leadership Team with responsibilities for developing and evolving short- and long-range Clinical Operations strategies, plans, processes, tools and infrastructure development. Alecia functions as a Clinical Operations Vendor Lead for strategic CRO partnerships, with accountability to develop relationships, identify cross-portfolio issues, elevate to governance committees, and lead effective multi-level engagement and communication with Gilead and with CRO partners.

Alecia obtained her pharmacy degree, higher diploma in Quality Management and a PhD in Pharmaceutics from Trinity College, University of Dublin.  Alecia has more than 15 years’ experience in the pharmaceutical industry across at various levels and positions in pharmaceutical development and clinical operations.